On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic

On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,…
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.
The fund seeks to…
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups
Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up…
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual…
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because…
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological…
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen
French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will…
Continue Reading Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
Cambridge startup biotechnology company Walden Biosciences announced its launch today with a $51 million Series A financing led by UCB
…
Continue Reading Cambridge Startup Walden Biosciences Launches With $50M Raise
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.